.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Sip is stocked at 119 licensed dispensaries across Arizona and Massachusetts, 77 of them in Arizona, with the deepest coverage in Phoenix, Tucson, Mesa, Tempe, and Sun City. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Sip concentrated 85.02% of sales in Beverage with year-over-year growth of 40.97% and month-over-month growth of 19.89%, while Tincture & Sublingual held 14.98% share with 35.95% YoY and 18.36% MoM. The portfolio’s weighted average price fell 4.35% YoY to $4.39 even as Beverage priced at $3.86 and Tincture & Sublingual at $19.75, indicating mix effects where an 85.02% Beverage share combines with 40.20% total brand YoY growth to pull average ticket lower. This pattern implies Sip is leaning into higher-velocity, lower-price Beverage units to drive volume expansion, using Tincture & Sublingual’s 14.98% share and 18.36% MoM as a secondary growth pillar rather than a margin-led anchor.
With Beverage ranked 7 in Massachusetts and growing 19.89% MoM alongside a 40.97% YoY lift, Sip’s positioning skews toward scale within a single category rather than diversification, while the 14.98% Tincture & Sublingual mix and 35.95% YoY suggest a targeted upsell lane. The combination of a 4.35% YoY price decline and an 85.02% Beverage share points to elasticity-driven volume capture, where incremental share gains are more likely to come from penetration in Beverage than trading customers up, and the October 2026 mix signals a strategy prioritizing rank advancement via unit growth over margin maximization.
Competitive Landscape
Sip sits at #7 in MA Beverage in October 2026, a 3-rank climb from #10 year over year, and up 1 position from #8 three months ago, marking a peak rank of #7 in October 2026; meanwhile, Levia held #1 with +15.5% YoY sales while Buzzy stayed at #3 with -14.2% YoY sales, and Squier's Elixirs advanced from #7 to #5 on +77.7% YoY sales, indicating that Sip’s incremental rank gains amid mixed competitor momentum point to a narrow window to consolidate share before faster risers compress the middle tier.
Notable Products
Sip sells at a discount in October 2026, with average prices 27.3% below similar products, and its leading items like Cherry Vanilla Seltzer and CBD/THC/CBN Sugar Free Couchlock Grape Infused Soda also sit 21% to 51% under peers. That pricing stance, paired with 0% of sales from new launches, points to sales coming from value-priced staples rather than recent additions.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
